Trial Profile
Bioequivalence of intravenous and oral formulations of the antiepileptic drug lacosamide
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Sep 2012
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary) ; Lacosamide (Primary)
- Indications Epilepsy; Fibromyalgia; Osteoarthritis; Pain; Sleep disorders; Tonic-clonic epilepsy
- Focus Pharmacokinetics
- Sponsors UCB Pharma AG
- 20 Sep 2012 New trial record